Clinical Trial Update: Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients [NA]

View source ↗

Summary

A completed clinical trial studied doxycycline to reduce sputum MMP-9 activity in adults with cystic fibrosis. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cystic Fibrosis | NA | Status: COMPLETED | Results posted: 2017-03-06